Hugo Peris, Spiral Therapeutics CEO

Hear­ing-fo­cused biotech grabs trio of pro­grams from Oton­o­my's fire sale

Oton­o­my may be shut­ting down, but the lessons learned there will live on at an­oth­er biotech work­ing on new treat­ments for hear­ing loss.

San Fran­cis­co …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.